Impact of fibroids on reproductive function

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 22, Issue 4, 2008, Pages 749-760

  Khaund, Aradhana ^a   Lumsden, Mary Ann ^b  

^a Glasgow Royal and Princess Royal Maternity Hospitals ^*  (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

ART; contraception; fibroids; infertility; leiomyomata; miscarriage; myomas; myomectomy; obstetric outcome; pregnancy loss; reproduction

Indexed keywords

ANTIBIOTIC AGENT; ESTROGEN; GESTAGEN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT; PROGESTERONE;

CESAREAN SECTION; CLINICAL TRIAL; DRUG EFFICACY; ENDOMETRITIS; FEMALE INFERTILITY; FEMALE SUBFERTILITY; FERTILIZATION IN VITRO; HORMONAL CONTRACEPTION; HUMAN; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; INTRAUTERINE GROWTH RETARDATION; LAPAROSCOPIC SURGERY; MENORRHAGIA; MYOMECTOMY; PELVIS PAIN SYNDROME; PLACENTA PREVIA; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRIORITY JOURNAL; REVIEW; SOLUTIO PLACENTAE; SPONTANEOUS ABORTION; TUMOR RECURRENCE; UTERINE ARTERY EMBOLIZATION; UTERUS MYOMA; UTERUS SYNECHIA;

ABORTION, SPONTANEOUS; CONTRACEPTIVES, ORAL; FEMALE; HUMANS; INFERTILITY, FEMALE; LEIOMYOMA; MYOMETRIUM; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; REPRODUCTIVE TECHNIQUES, ASSISTED; TREATMENT OUTCOME; UTERINE ARTERY EMBOLIZATION; UTERINE NEOPLASMS;

EID: 46549085583     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2008.01.009     Document Type: Review

References (61)

1. Buttram Jr. V.C., and Reiter R.C. Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril 36 (1981) 433-445
2. Deligdish L., and Loewenthal M. Endometrial changes associated with myomata of the uterus. J Clin Pathol 23 (1970) 676-680
3. Casini M.L., Rossi F., Agostini R., et al. Effects of the position of fibroids on fertility. Gynecol Endocrinol 22 (2006) 106-109
4. Richards P.A., Richards P.D., and Tiltman A.J. The ultrastructure of fibromyomatous myometrium and its relationship to infertility. Hum Reprod Update 4 (1998) 520-525
5. Eldar-Geva T., Meagher S., Healy D.L., et al. Effect of intramural, subserosal, and submucosal uterine fibroids on the outcome of assisted reproductive technology treatment. Fertil Steril 70 (1998) 687-691
6. Farrer-Brown G., Beilby J.O., and Tarbit M.H. Venous changes in the endometrium of myomatous uteri. Obstet Gynecol 38 (1971) 743-751
7. Check J.H., Choe J.K., Lee G., et al. The effect on IVF outcome of small intramural fibroids not compressing the uterine cavity as determined by a prospective matched control study. Hum Reprod 17 (2002) 1244-1248
8. Hart R., Khalaf Y., Yeong C.T., et al. A prospective controlled study of the effect of intramural uterine fibroids on the outcome of assisted conception. Hum Reprod 16 (2001) 2411-2417
9. Oliveira F.G., Abdelmassih V.G., Diamond M.P., et al. Impact of subserosal and intramural uterine fibroids that do not distort the endometrial cavity on the outcome of in vitro fertilization-intracytoplasmic sperm injection. Fertil Steril 81 (2004) 582-587
10. Farhi J., Ashkenazi J., Feldberg D., et al. Effect of uterine leiomyomata on the results of in-vitro fertilization treatment. Hum Reprod 10 (1995) 2576-2578
11. Stovall D.W., Parrish S.B., Van Voorhis B.J., et al. Uterine leiomyomas reduce the efficacy of assisted reproduction cycles: results of a matched follow-up study. Hum Reprod 13 (1998) 192-197
12. Surrey E.S., Lietz A.K., and Schoolcraft W.B. Impact of intramural leiomyomata in patients with a normal endometrial cavity on in vitro fertilization-embryo transfer cycle outcome. Fertil Steril 75 (2001) 405-410
13. Pritts E.A. Fibroids and infertility: a systematic review of the evidence. Obstet Gynecol Surv 56 (2001) 483-491
14. Nezhat F.R., Roemisch M., Nezhat C.H., et al. Recurrence rate after laparoscopic myomectomy. J Am Assoc Gynecol Laparosc 5 (1998) 237-240
15. Manyonda I., Sinthamoney E., and Belli A.M. Controversies and challenges in the modern management of uterine fibroids. BJOG 111 (2004) 95-102
16. Surrey E.S., Minjarez D.A., Stevens J.M., et al. Effect of myomectomy on the outcome of assisted reproductive technologies. Fertil Steril 83 (2005) 1473-1479
17. Dubuisson J.B., Fauconnier A., Chapron C., et al. Reproductive outcome after laparoscopic myomectomy in infertile women. J Reprod Med 45 (2000) 23-30
18. Rossetti A., Sizzi O., Soranna L., et al. Fertility outcome: long-term results after laparoscopic myomectomy. Gynecol Endocrinol 15 (2001) 129-134
19. Seracchioli R., Rossi S., Govoni F., et al. Fertility and obstetric outcome after laparoscopic myomectomy of large myomata: a randomized comparison with abdominal myomectomy. Hum Reprod 15 (2000) 2663-2668
20. Ubaldi F., Tournaye H., Camus M., et al. Fertility after hysteroscopic myomectomy. Hum Reprod Update 1 (1995) 81-90
21. Griffiths A., D'Angelo A., and Amso N. Surgical treatment of fibroids for subfertility. Cochrane Database Syst Rev 3 (2006) CD003857
22. Kolankaya A., and Arici A. Myomas and assisted reproductive technologies: when and how to act?. Obstet Gynecol Clin North Am 33 (2006) 145-152
23. Somigliana E., Vercellini P., Daguati R., et al. Fibroids and female reproduction: a critical analysis of the evidence. Hum Reprod Update 13 (2007) 465-476
24. Palomba S., Zupi E., Russo T., et al. A multicenter randomized, controlled study comparing laparoscopic versus minilaparotomic myomectomy: short-term outcomes. Fertil Steril 88 (2007) 942-951
25. Muram D., Gillieson M., and Walters J.H. Myomas of the uterus in pregnancy: ultrasonographic follow-up. Am J Obstet Gynecol 138 (1980) 16-19
26. Rosati P., Bellati U., Exacoustos C., et al. Uterine myoma in pregnancy: ultrasound study. Int J Gynaecol Obstet 28 (1989) 109-117
27. Benson C.B., Chow J.S., Chang-Lee W., et al. Outcome of pregnancies in women with uterine leiomyomas identified by sonography in the first trimester. J Clin Ultrasound 29 (2001) 261-264
28. Li T.C., Mortimer R., and Cooke I.D. Myomectomy: a retrospective study to examine reproductive performance before and after surgery. Hum Reprod 14 (1999) 1735-1740
29. Practice Committee of the American Society for Reproductive Medicine. Myomas and reproductive function. Fertil Steril 82 Suppl. 1 (2004) S111-S116
30. Seracchioli R., Manuzzi L., Vianello F., et al. Obstetric and delivery outcome of pregnancies achieved after laparoscopic myomectomy. Fertil Steril 86 (2006) 159-165
31. Vercellini P., Maddalena S., De Giorgi O., et al. Determinants of reproductive outcome after abdominal myomectomy for infertility. Fertil Steril 72 (1999) 109-114
32. Coronado G.D., Marshall L.M., and Schwartz S.M. Complications in pregnancy, labor, and delivery with uterine leiomyomas: a population-based study. Obstet Gynecol 95 (2000) 764-769
33. Qidwai G.I., Caughey A.B., and Jacoby A.F. Obstetric outcomes in women with sonographically identified uterine leiomyomata. Obstet Gynecol 107 (2006) 376-382
34. Davis J.L., Ray-Mazumder S., Hobel C.J., et al. Uterine leiomyomas in pregnancy: a prospective study. Obstet Gynecol 75 (1990) 41-44
35. Katz V.L., Dotters D.J., and Droegemeuller W. Complications of uterine leiomyomas in pregnancy. Obstet Gynecol 73 (1989) 593-596
36. Rice J.P., Kay H.H., and Mahony B.S. The clinical significance of uterine leiomyomas in pregnancy. Am J Obstet Gynecol 160 (1989) 1212-1216
37. Golan D., Aharoni A., Gonen R., et al. Early spontaneous rupture of the post myomectomy gravid uterus. Int J Gynaecol Obstet 31 (1990) 167-170
38. Verkauf B.S. Myomectomy for fertility enhancement and preservation. Fertil Steril 58 (1992) 1-15
39. Faerstein E., Szklo M., and Rosenshein N.B. Risk factors for uterine leiomyoma: a practice-based case-control study. II. Atherogenic risk factors and potential sources of uterine irritation. Am J Epidemiol 153 (2001) 11-19
40. Ross R.K., Pike M.C., Vessey M.P., et al. Risk factors for uterine fibroids: reduced risk associated with oral contraceptives. [Erratum appears in British Medical Journal Clinical Research Ed 1986; 293: 1027.]. British Medical Journal Clinical Research Ed 293 (1986) 359-362
41. Parazzini F., Negri E., La Vecchia C., et al. Reproductive factors and risk of uterine fibroids. Epidemiology 7 (1996) 440-442
42. Romieu I., Walker A.M., and Jick S. Determinants of uterine fibroids. Post Mark Surveill 5 (1991) 119-133
43. Ramcharan S., Pellegrin F.A., Ray R.M., et al. The Walnut Creek Contraceptive Drug Study. A prospective study of the side effects of oral contraceptives. Volume III, an interim report: a comparison of disease occurrence leading to hospitalization or death in users and nonusers of oral contraceptives. J Reprod Med 25 Suppl. (1980) 345-372
44. Marshall L.M., Spiegelman D., Goldman M.B., et al. A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata. Fertil Steril 70 (1998) 432-439
45. Orsini G., Laricchia L., and Fanelli M. Low-dose combination oral contraceptives use in women with uterine leiomyomas. Minerva Ginecol 54 (2002) 253-261 [in Italian]
46. Wise L.A., Palmer J.R., Harlow B.L., et al. Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: a prospective study. Am J Epidemiol 159 (2004) 113-123
47. Venkatachalam S., Bagratee J.S., and Moodley J. Medical management of uterine fibroids with medroxyprogesterone acetate (Depo Provera): a pilot study. J Obstet Gynaecol 24 (2004) 798-800
48. Maruo T. Progesterone and progesterone receptor modulator in uterine leiomyoma growth. Gynecol Endocrinol 23 (2007) 186-187
49. Rosa e Silva J.C., de Sa Rosa e Silva A.C., dos Reis F.J., et al. Use of a levonorgestrel-releasing intrauterine device for the symptomatic treatment of uterine myomas. J Reprod Med 50 (2005) 613-617
50. Magalhaes J., Aldrighi J.M., and de Lima G.R. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas. Contraception 75 (2007) 193-198
51. Kaunitz A.M. Progestin-releasing intrauterine systems and leiomyoma. Contraception 75 Suppl. (2007) S130-S133
52. Ravina J.H., Herbreteau D., Ciraru-Vigneron N., et al. Arterial embolisation to treat uterine myomata. Lancet 346 (1995) 671-672
53. Spies JB, Cooper JM, Worthington-Kirsch R, et al. Outcome of uterine embolization and hysterectomy for leiomyomas: results of a multicenter study. Am J Obstet Gynecol 191: 22-31.
54. Spies J.B., Bruno J., Czeyda-Pommersheim F., et al. Long-term outcome of uterine artery embolization of leiomyomata. Obstet Gynecol 106 (2005) 933-939
55. Walker W.J., and Pelage J.P. Uterine artery embolisation for symptomatic fibroids: clinical results in 400 women with imaging follow up. BJOG 109 (2002) 1262-1272
56. Scheurig C., Gauruder-Burmester A., Kluner C., et al. Uterine artery embolization for symptomatic fibroids: short-term versus mid-term changes in disease-specific symptoms, quality of life and magnetic resonance imaging results. Hum Reprod 21 (2006) 3270-3277
57. Edwards R.D., Moss J.G., Lumsden M.A., et al. Uterine-artery embolization versus surgery for symptomatic uterine fibroids. N Engl J Med 356 (2007) 360-370
58. Spies J.B., Coyne K., Guaou G.N., et al. The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstet Gynecol 99 (2002) 290-300
59. Ahmad A., Qadan L., Hassan N., et al. Uterine artery embolization treatment of uterine fibroids: effect on ovarian function in younger women. J Vasc Interv Radiol 13 (2002) 1017-1020
60. Goldberg J, Pereira L, Berghella V, et al. Pregnancy outcomes after treatment for fibromyomata: uterine artery embolization versus laparoscopic myomectomy. Am J Obstet Gynecol 191; 18-21.
61. Mara M., Fucikova Z., Maskova J., et al. Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial. Eur J Obstet Gynecol Reprod Biol 126 (2006) 226-233